Prenetics Global Ltd (PRE)
4.81
-0.07
(-1.43%)
USD |
NASDAQ |
Nov 14, 16:00
4.49
-0.32
(-6.65%)
After-Hours: 20:00
Prenetics Global Shareholders Equity (Quarterly): 188.24M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 188.24M |
| March 31, 2024 | 199.44M |
| December 31, 2023 | 206.36M |
| September 30, 2023 | 224.44M |
| June 30, 2023 | 215.31M |
| March 31, 2023 | 228.25M |
| Date | Value |
|---|---|
| December 31, 2022 | 237.06M |
| September 30, 2022 | 207.35M |
| June 30, 2022 | 219.09M |
| March 31, 2022 | -424.95M |
| December 31, 2021 | -400.81M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-424.95M
Minimum
Mar 2022
237.06M
Maximum
Dec 2022
99.98M
Average
207.35M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 4.519B |
| HUTCHMED (China) Ltd | 740.08M |
| Pharmaron Beijing Co Ltd | 1.595B |
| Regencell Bioscience Holdings Ltd | 8.219M |
| Uni-Bio Science Group Ltd | 40.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 233.31M |
| Total Liabilities (Quarterly) | 42.30M |
| Current Ratio | 2.055 |